IE00BYZK4776
IE00BYZK4776
iShares Healthcare Innovation UCITS ETF
Loading chart...
About this ETF
The iShares Healthcare Innovation UCITS ETF seeks to track the iSTOXX® FactSet Breakthrough Healthcare index. The iSTOXX® FactSet Breakthrough Healthcare index tracks companies across the world that are focused on innovation within global healthcare services, across both developed and emerging markets.
TER
0.4%
Total Expense Ratio per year
Fund Size
€1.19B
Assets under management
Holdings
200
Underlying equities
Dividend Yield
0%
Accumulating
Fundamentals & Estimates
Weighted valuation multiples and analyst forecasts
Valuation Multiples
Weighted P/E
25.58
Weighted Fwd P/E
33.51
💰 Revenue Estimates
Current Year CY
+18.6% ⌀ 16 Analysts Coverage
Next Year NY
+112.17% ⌀ 17 Analysts Coverage
📈 EPS Estimates (Earnings Per Share)
Current Year CY
-441.39% ⌀ 15 Analysts Coverage
Next Year NY
+70.01% ⌀ 15 Analysts Coverage
Related ETFs
Xtrackers World Green Tech Innovators UCITS ETF 1C
34.94 EUR
TER 0.35% 1Y +15.8%
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C
44.06 USD
TER 0.3% 1Y +71.1%
ETF Profile
Provider
Fund Type
ETF Type
Passive Inception Date
09/08/2016 (10 yrs)
Index Group
iSTOXX FactSet Thematic Region
World Country
-
Sector
Health Care Strategy
Social / Environmental Theme
Innovation Distribution Policy
Accumulating Replication
Optimized sampling Sustainable
Yes 🛡️ Risk & Structural Analysis
Multi-Factor Risk Model & Market Data
5/7 Elevated
Diversification Score: 34/100 Low (Concentration Risk)
Diversification Score
34/100 Low (Concentration Risk)
5Y Volatility
20.0% p.a.
Max Drawdown (5Y)
-40.9%
Sharpe Ratio (5Y)
-0.04
Beta Factor
1.12
Notes & Warnings
Fund Volume (AUM) 🟢 Established large fund (> 500M € AUM)
🟡 Moderate analyst coverage (14.9 analysts)
🔴 Severe sector concentration risk: 98% in "Healthcare".
⚠️ Industry concentration: 36% in "Biotechnology".
⚠️ Elevated Regulatory & Policy Risk: 98% in heavily regulated industries (defense, regulated utilities, healthcare policy).
⚠️ Historical Stress Test: Maximum peak-to-trough drawdown of -40.9% in the extended horizon.